JP2019512262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512262A5 JP2019512262A5 JP2018560245A JP2018560245A JP2019512262A5 JP 2019512262 A5 JP2019512262 A5 JP 2019512262A5 JP 2018560245 A JP2018560245 A JP 2018560245A JP 2018560245 A JP2018560245 A JP 2018560245A JP 2019512262 A5 JP2019512262 A5 JP 2019512262A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- acid sequence
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16154507.4A EP3202788A1 (en) | 2016-02-05 | 2016-02-05 | Endosialin-binding antibody |
| EP16154507.4 | 2016-02-05 | ||
| PCT/EP2017/052399 WO2017134234A1 (en) | 2016-02-05 | 2017-02-03 | Endosialin-binding antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019512262A JP2019512262A (ja) | 2019-05-16 |
| JP2019512262A5 true JP2019512262A5 (enExample) | 2020-03-12 |
| JP7094893B2 JP7094893B2 (ja) | 2022-07-04 |
Family
ID=55310735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560245A Expired - Fee Related JP7094893B2 (ja) | 2016-02-05 | 2017-02-03 | エンドシアリン結合抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11318210B2 (enExample) |
| EP (2) | EP3202788A1 (enExample) |
| JP (1) | JP7094893B2 (enExample) |
| AU (1) | AU2017216284A1 (enExample) |
| CA (1) | CA3012270A1 (enExample) |
| WO (1) | WO2017134234A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021521273A (ja) * | 2018-04-12 | 2021-08-26 | メディアファーマ エス．アール．エル． | Ｌｇａｌｓ３ｂｐ抗体−薬剤結合体及びがん治療のためのその使用 |
| EP3880706A1 (en) * | 2018-11-12 | 2021-09-22 | MediaPharma S.r.l. | Bispecific antibodies directed against human 90k and either endosialin or her3 |
| KR20210099073A (ko) | 2018-12-03 | 2021-08-11 | 퓨전 파마슈티칼즈 인크. | 방사성면역접합체와 체크포인트 억제제의 조합 요법 |
| EP3976091A4 (en) * | 2019-05-31 | 2023-07-26 | Ludwig Institute for Cancer Research Ltd | ANTI-TEM1 ANTIBODIES AND THEIR ANTIGEN-BINDING PARTS |
| AU2020397210A1 (en) | 2019-12-06 | 2022-07-28 | Ablynx Nv | Polypeptides comprising immunoglobulin single variable domains targeting TNFa and OX40L |
| WO2021207086A1 (en) * | 2020-04-06 | 2021-10-14 | Fusion Pharmaceuticals Inc. | Tem-1-targeted radioimmunoconjugates and uses thereof |
| WO2022129572A1 (en) | 2020-12-18 | 2022-06-23 | Ablynx Nv | Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| KR900700134A (ko) | 1988-04-15 | 1990-08-11 | 원본미기재 | Il-2 수용체-특이적 키메릭 항체 |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO2006017759A2 (en) * | 2004-08-05 | 2006-02-16 | Kirin Brewery Co., Ltd. | Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof |
| ITRM20090081A1 (it) | 2009-02-25 | 2010-08-26 | Stefano Iacobelli | Uso di inibitori della proteina 90k per la preparazione di un medicamento per la cura o prevenzione dei tumori. |
| US20100260769A1 (en) * | 2009-04-09 | 2010-10-14 | Morphotek, Inc. | Endosialin binding molecules |
| WO2012176779A1 (ja) * | 2011-06-20 | 2012-12-27 | 協和発酵キリン株式会社 | 抗ｅｒｂＢ３抗体 |
| EP2831114B1 (en) * | 2012-03-30 | 2019-05-08 | Eisai R&D Management Co., Ltd. | Tem-1 diagnostic antibodies |
-
2016
- 2016-02-05 EP EP16154507.4A patent/EP3202788A1/en not_active Ceased
-
2017
- 2017-02-03 US US16/075,849 patent/US11318210B2/en not_active Expired - Fee Related
- 2017-02-03 JP JP2018560245A patent/JP7094893B2/ja not_active Expired - Fee Related
- 2017-02-03 WO PCT/EP2017/052399 patent/WO2017134234A1/en not_active Ceased
- 2017-02-03 CA CA3012270A patent/CA3012270A1/en active Pending
- 2017-02-03 EP EP17703724.9A patent/EP3411405A1/en not_active Withdrawn
- 2017-02-03 AU AU2017216284A patent/AU2017216284A1/en not_active Abandoned
-
2022
- 2022-03-29 US US17/707,838 patent/US20220218836A1/en not_active Abandoned